Multi-Component Formulation for Alzheimer's Neuroprotection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Alzheimer's disease are limited in addressing the multifactorial nature of the condition, with existing drugs often having minimal side effects but being animal-derived, raising concerns about disease transmission, and lacking a comprehensive approach to counter the various contributing factors such as inflammation, oxidative stress, and impaired cerebral blood flow.
Innovation Solution
A multi-component formulation combining dimethyl sulfoxide (DMSO), energy sources like fructose-6-phosphate or fructose 1,6-diphosphate, herbal components like curcumin and wolfberry, and nutritional components like omega-3 fatty acids and resveratrol, which work synergistically to counter multiple contributing factors to Alzheimer's disease, promoting neuroprotection and cognitive health.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If animal-derived treatments like Cerebrolysin are used, then neuroprotective effects are achieved, but concerns about disease transmission arise
Solution Approach 1:
The patent extracts the active neuroprotective components from animal-derived sources and formulates them as synthetic or plant-based alternatives. Specifically, it uses human brain-derived peptides synthesized in vitro, plant extracts (curcumin, resveratrol, omega-3 fatty acids), and purified active ingredients that replicate the neuroprotective effects without animal involvement, thereby eliminating disease transmission risks while maintaining therapeutic efficacy.
Solution Approach 2:
The patent changes the source parameter of the active ingredients from animal-derived to plant-derived or synthetically produced. It transforms the composition from animal proteins to a multi-component formulation including curcumin (from turmeric), resveratrol (from grapes), omega-3 fatty acids (from fish oil or plant sources), and human brain-derived peptides synthesized through cell culture, fundamentally altering the origin parameter while preserving therapeutic function.
2Ease of operation
If single-component drugs are used, then simplicity of administration is maintained, but comprehensive treatment of multifactorial AD is insufficient
Solution Approach 1:
The patent merges multiple active ingredients with complementary mechanisms of action into a single unified formulation. It combines curcumin (anti-inflammatory), resveratrol (antioxidant), omega-3 fatty acids (neural membrane protection), and human brain-derived peptides (neurotrophic) into one multi-component treatment that simultaneously addresses multiple pathogenic factors of Alzheimer's disease, maintaining ease of administration while achieving comprehensive treatment coverage.
Solution Approach 2:
The patent creates a multi-functional formulation that performs multiple therapeutic functions simultaneously. The combined ingredients provide antioxidant protection, anti-inflammatory effects, neurotrophic support, and neuronal membrane stabilization all within a single treatment protocol, enabling one intervention to address the multifactorial nature of Alzheimer's disease rather than requiring multiple separate treatments.
3Ease of manufacture
If traditional single-drug treatments are used, then regulatory approval is easier obtained, but ability to counter multiple contributing factors is limited
Solution Approach 1:
The patent segments the treatment approach into distinct functional components, each targeting specific pathogenic mechanisms. It divides the therapeutic action into antioxidant protection (resveratrol, curcumin), anti-inflammatory effects (curcumin, omega-3s), neurotrophic support (human brain-derived peptides), and membrane protection (omega-3 fatty acids), allowing each component to be optimized and regulated separately while working synergistically as a unified treatment strategy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation effectively delays or prevents cognitive decline by restoring balance, enhancing cerebral blood flow, and stimulating neuroprotective proteins, offering a safer and more comprehensive approach compared to traditional treatments.
Implementation Method 1
It is a chemical chaperone which has reduced protein misfolding in prion diseases
Implementation Method 2
DMSO, by itself and in combination with FDP, has many desirable effects. It is a powerful antioxidant
Implementation Method 3
It increases cerebral blood flow without altering blood pressure when significant cell damage is present
Implementation Method 4
The formulation combines dimethyl sulfoxide (DMSO), energy sources like fructose-6-phosphate or fructose 1,6-diphosphate, herbal components like curcumin and wolfberry, and nutritional components like omega-3 fatty acids and resveratrol, which work synergistically to counter multiple contributing factors to Alzheimer's disease, promoting neuroprotection and cognitive health.
Data Source
AI summary
A multi-component formulation for the treatment, delay, and/or prevention of cognitive decline, including Alzheimer's disease, and/or other neurodegenerative diseases. One embodiment of the multi-component formulation comprises methylsulfonylmethane, at least one energy source component, and at least one of an herbal component or a nutritional component. In one formulation, the energy source component is fructose 1,6-diphosphate. An herbal component of at least one formulation is curcumin. In one further formulation, a nutritional component is a component of green tea such as epigallocatechin-3-gallate.